The most common side effect of nitrous oxide (N₂O) in children is vomiting (2–14% depending on the setting), while the overall rate of adverse events is 4–17% and serious adverse events are extremely rare (0.1–0.2%). The vast majority of side effects are minor and self-limiting. [1][2]
Rate and range of side effects: data from large registries
| Study | n | Overall AE rate | Vomiting | Nausea | Serious AEs | Source |
|---|---|---|---|---|---|---|
| Zier et al. (7,802 sedations, 5.5 years) | 7802 | 4.3% | 2.2% | 1.6% | 0.12% (9 cases, all resolved) | [1] |
| PSRC (Tsze et al., 40 centers) | 1634 | 6.5% | 2.4% | — | 0.2% (3 cases) | [2] |
| Babl et al. (N₂O 50–70%) | 762 | 8.3% | 5.7% | — | 0.2% (2 cases) | [3] |
| Croughan et al. (10 years, N₂O ± fentanyl) | 831 | 16.5% | 13.6% | — | 0% | [4] |
| Galeotti et al. (dentistry, N₂O ≤50%) | 688 | 2.5% | 1.2% | — | 0% | [5] |
None of the large registries recorded a single case of aspiration, conversion to intubation or death. [1-3]
II. Minor side effects (self-limiting)
Vomiting is the most clinically relevant minor effect. Factors that increase the risk: [2][4][6]
- Concomitant use of opioids: OR 2.89 (95% CI 1.14–7.32); with N₂O + intranasal fentanyl, vomiting reaches 14% (RR 1.8 compared with N₂O alone) [2][4]
- Clear fluids less than 2 hours before the procedure: OR 4.16 (95% CI 1.61–10.76) [2]
- Procedure duration: over 15 min the risk of AEs rises 4.2-fold, over 30 min 4.9-fold compared with under 15 min [1]
- A higher fentanyl dose: each dose increase raises the risk of vomiting by 30% (RR 1.3) [6]
Other minor effects: nausea (1.6–4.4%), dizziness (rate not standardized, but mentioned as common), dysphoria or agitation (3.7% according to the meta-analysis by Poonai et al.) [8], euphoria and laughter (an expected pharmacological effect, not an AE), transient voice change, sweating or diaphoresis (0.4%). [5][7]
III. Serious side effects (rare)
Respiratory. Desaturation (SpO₂ <90%) is extremely rare with N₂O alone: the largest registry (n=7,802) recorded only 9 potentially serious events, all of which resolved without consequences. The most clinically relevant respiratory effect is a dose-dependent depression of the ventilatory response to hypoxemia, which is potentiated by other sedatives. Unintended deep sedation: with 70% N₂O by continuous flow, moderate or deep sedation was seen in 3% of children, and with 50% N₂O in 0%. [1][3][7]
Diffusion hypoxia
When N₂O is stopped abruptly, rapid diffusion of the gas from the blood into the alveoli dilutes alveolar oxygen, which can cause a transient drop in saturation. The classic study by Fink (1955) described a 5–10% drop in saturation within 10 minutes of stopping N₂O. However, the pediatric study by Dunn-Russell et al. showed that in healthy children breathing room air, SpO₂ fluctuations were under 1% and did not reach clinically significant levels. Nevertheless, standard practice is to give 100% O₂ for 3–5 minutes after stopping N₂O to prevent diffusion hypoxia. [9][10]
IV. Effect on vitamin B₁₂ and methionine synthase
N₂O irreversibly oxidizes the cobalt in vitamin B₁₂, inactivating methionine synthase. This leads to a rise in homocysteine and impaired DNA methylation. [11][12]
The pediatric study by Pichardo et al. (Anesthesiology, 2012, n=32 children) showed that N₂O exposure of 2 hours or more causes a statistically significant 25% increase in homocysteine (from 5.1 to 6.4 µM) after 24 hours, and in 21% of children with initially normal levels, homocysteine exceeded the age norm. The duration of exposure was a strong predictor of the increase (R²=0.696). [11]
Clinical relevance for short procedural sedation (5–15 min): with a single short exposure, inactivation of methionine synthase is minimal and clinically insignificant. The risk rises with long exposures (2 hours or more), frequent repeated exposures and pre-existing vitamin B₁₂ deficiency — in that case even a single exposure can trigger neurological complications. [12][13]
V. Effect of combination with other drugs
The systematic review by Poonai et al. (CJEM, 2023, 30 RCTs) showed that the rate of adverse events rises sharply when N₂O is combined with other sedatives: [8]
| Regimen | Rate of any AEs | Source |
|---|---|---|
| N₂O alone | 24.2% (278/1147) | [1] |
| N₂O + fentanyl | 61.2% (123/201) | [1] |
| N₂O + midazolam | 92.3% (48/52) | [1] |
This highlights that the safety profile of N₂O worsens considerably when other sedatives or analgesics are added, and most serious adverse events in the literature are linked to combined regimens. [8]
VI. Factors that modify the risk of AEs
| Factor | Effect on risk | Data | Source |
|---|---|---|---|
| Duration >15 min | 4.2-fold increase | n=7802 | [1] |
| Duration >30 min | 4.9-fold increase | n=7802 | [1] |
| Combination with opioids | more vomiting (OR 2.89) | n=1634 | [2] |
| NPO <2 h (clear fluids) | more vomiting (OR 4.16) | n=1634 | [2] |
| Age 1–4 years | fewer AEs (lowest rate) | n=7802 | [1] |
| N₂O concentration (50% vs 70%) | no significant difference | n=762, n=7802 | [1][3] |
| Continuous flow vs demand valve | more vomiting (4% vs 0%) | review | [4] |
Summary
Nitrous oxide alone has an excellent safety profile in children: no life-threatening events have been described in any large registry. The main side effect is vomiting (2–6% with N₂O alone), and its risk is minimized by a short procedure (under 15 min), avoiding combination with opioids and fasting for at least 2 hours for clear fluids. Diffusion hypoxia is clinically insignificant in healthy children, but standard practice is to give 100% O₂ after stopping N₂O. The effect on vitamin B₁₂ with short single exposures is minimal, but with repeated or long sedations the risk of methionine synthase inactivation should be taken into account, especially in children with pre-existing B₁₂ deficiency. [1-3][7][11]
Sources
- 1.Practice Patterns and Adverse Events of Nitrous Oxide Sedation and Analgesia: A Report From the Pediatric Sedation Research Consortium. The Journal of Pediatrics, 2016. Tsze DS, Mallory MD, Cravero JP.
- 2.Safety and Efficacy of a Nitrous Oxide Procedural Sedation Programme in a Paediatric Emergency Department: A Decade of Outcomes. Emergency Medicine Journal, 2023. Croughan S, Barrett M, O'Sullivan R, Beegan A, Blackburn C.
- 3.High-Concentration Nitrous Oxide for Procedural Sedation in Children: Adverse Events and Depth of Sedation. Pediatrics, 2008. Babl FE, Oakley E, Seaman C, Barnett P, Sharwood LN.
- 4.Inhalation Conscious Sedation with Nitrous Oxide and Oxygen as Alternative to General Anesthesia in Precooperative, Fearful, and Disabled Pediatric Dental Patients: A Large Survey on 688 Working Sessions. BioMed Research International, 2016. Galeotti A, Garret Bernardin A, D'Antò V, et al.
- 5.Procedural Sedation and Analgesia in Children. Lancet, 2006. Krauss B, Green SM.
- 6.Associations With Early Vomiting When Using Intranasal Fentanyl and Nitrous Oxide for Procedural Sedation in Children: A Secondary Analysis of a Randomised Controlled Trial. Emergency Medicine Australasia, 2025. Fauteux-Lamarre E, Hearps S, McCarthy M, et al.
- 7.Applications of Nitrous Oxide for Procedural Sedation in the Pediatric Population. Pediatric Emergency Care, 2013. Tobias JD.
- 8.Inhaled Nitrous Oxide for Painful Procedures in Children and Youth: A Systematic Review and Meta-Analysis. CJEM, 2023. Poonai N, Creene C, Dobrowlanski A, et al.
- 9.An Early Example of Evidence-Based Medicine: Hypoxemia Due to Nitrous Oxide. Anesthesiology, 2007. Cheney FW.
- 10.Oxygen Saturation and Diffusion Hypoxia in Children Following Nitrous Oxide Sedation. Pediatric Dentistry, 1993. Dunn-Russell T, Adair SM, Sams DR, Russell CM, Barenie JT.
- 11.Effect of Nitrous Oxide Exposure During Surgery on the Homocysteine Concentrations of Children. Anesthesiology, 2012. Pichardo D, Luginbuehl IA, Shakur Y, et al.
- 12.Vitamin B12, Folic Acid, and the Nervous System. The Lancet Neurology, 2006. Reynolds E.
- 13.Nitrous Oxide Misuse. The Journal of the American Medical Association, 2026. Raciti CD, Ehlers PF, LeSaint KT.
- 14.Risk Reduction in Pediatric Procedural Sedation by Application of an American Academy of Pediatrics/American Society of Anesthesiologists Process Model. Pediatrics, 2002. Hoffman GM, Nowakowski R, Troshynski TJ, Berens RJ, Weisman SJ.
- 15.Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures: Update 2016. Pediatric Dentistry, 2018.
- 16.Chinese Society of Pediatric Anesthesiology Guideline for Pediatric Sedation (2025). Paediatric Anaesthesia, 2026. Song X, Lei D, Cui Y, et al.
- 17.Safe pediatric procedural sedation and analgesia by anesthesiologists for elective procedures: A clinical practice statement from the European Society for Paediatric Anaesthesiology. Paediatric Anaesthesia, 2019. Zielinska M, Bartkowska-Sniatkowska A, Becke K, et al.
Still have questions?
Book a consultation with a specialist
Book
